作者
Pankaj Kumar, Bharti Mangla, Satbir Singh, Arapna Rana
发表日期
2017/12/1
期刊
INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷号
4
期号
12
页码范围
4705-+
出版商
SSJ COLL PHARMACY-SSJCP
简介
Different regulatory authorities regulate the drug development in various countries of the world. Various Regulatory authority for generic drug application Food and Drug Administration (FDA), European Medicines Agency (EMA), Pharmaceutical and Medical Devices Agency (PMDA), Health Product and Food Branch (HPFB) Central Drug Standard of Organization (CDSO). Generic manufacturers may file an abbreviated New Drug Application (ANDA) that incorporates the safety/effectiveness data submitted by original innovator drug manufacturer and adds only bioequivalence studies. Therefore it is very difficult and challenging task to approve a drug by the manufacturing companies, simultaneously submitted in all regulatory authorities. Regulatory authorities are responsible to ensure the quality, safety, and efficacy including manufacturing, distribution of the drug product. There is lot of challenges for the …
引用总数
学术搜索中的文章
P Kumar, B Mangla, S Singh, A Rana - INDO AMERICAN JOURNAL OF PHARMACEUTICAL …, 2017